Proactive Investors - Run By Investors For Investors

Breakfast News - AIM Breakfast : 21st Century, Caspian Sunrise, Deltex Medical Group plc, Flying Brands Ltd, Ncondezi Energy, Premaitha Health, PowerHouse Energy, Plastics Capital Plc, Scientific Digital Imaging, Strategic Minerals Plc

Breakfast News - AIM Breakfast : 21st Century, Caspian Sunrise, Deltex Medical Group plc, Flying Brands Ltd, Ncondezi Energy, Premaitha Health, PowerHouse Energy, Plastics Capital Plc, Scientific Digital Imaging, Strategic Minerals Plc

What’s cooking in the IPO kitchen?

AIM

Touchstone Exploration— Oil exploration and production company active in the Republic of Trinidad and Tobago.  Interests of approximately 90,000 gross acres. Production c. 1,300 boepd. Raising £1.45m. Expected mkt cap £7.5m. Due 26 June.

I3 Energy –Schedule 1. Independent oil and gas company with assets and operations in the UK.  Offer TBC, 26 May admission.

Verditek— Schedule 1 update. On Admission, the Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Issue price 10p.  Admission in late May.

Tiso Blackstar Group—Schedule 1 update. Media, entertainment and marketing solutions group/ £160m mkt cap. Admission only. Expected late June.

Main Market Premium Listing

Curzon Energy—Report on Proactive Investors of intended LSE float this year  with acquisition of  coal bed methane assets in Oregon. Looking to raise £3m plus.

NLB Group—financial and banking institution based in Slovenia, with a network of 356 branches. Seeking Ljubliana Stock Exchange listing with GDRs on the LSE. Expected mid June.

Flying Brands (LON:FBDU)—Prospectus approved by FCA. RTO of Stone Checker Software,  supplier of technology solutions in the field of kidney stone analysis and prevention. Has raised £550k at 3p. Subject to GM on 15 Jun.

AEW UK Long Lease REIT—Intention to Float. Up to £150m raise. Admission early June. UK specialist and alternative property

Kuwait Energy— $150m raise plus vendor offer. Admission due June.  2p reserves 810.0 mmboe

Main Market Standard Listing

ADES International— Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa, seeking raise up to $170m plus vendor sale under a Standard Listing of the Main Market. Admission due May 2017.

Main Market Specialist Funds

PRS REIT—Private rental sector REIT raising up to £250m.  Admission due 31 May

  
  
 
Breakfast buffet

P2P Global Investments (LON:P2P) 877.5p £723.64m

Monthly update. 45bps NAV growth in the month

 

·    Continuing evolution of the portfolio towards new origination channels and secured asset classes, with more attractive risk return profiles

 

·    Share buybacks during the month contributed 7bps versus 16bps last month to NAV per share growth

 

·    12 pence dividend declared for the first quarter of 2017

 

·    35th consecutive month of positive NAV growth since inception

Ncondezi Energy (LON:NCCL) 2.13p £5.3m

Ncondezi has suspended exclusive discussions with Shanghai Electric Power Co., Ltd ("SEP") regarding its Joint Development Agreement ("JDA"). Exclusivity arrangements with SEP have lapsed and Ncondezi will now engage with additional strategic partners who have expressed an unsolicited interest in developing the project alongside Ncondezi.  Furthermore the Company has received indications of interest for an additional US$350k shareholder loan which would fund the Company until 2 September. Ncondezi believes that the ongoing delays in SEP funding the Project is unsustainable and that it is now in the best interests of the Company and its shareholders to suspend exclusive discussions with SEP and to enter into discussions with alternative potential partners.

Plastics Capital (LON:PLA) 122.5p £43.79m

The niche plastics products group, today announces a conditional placing to raise approximately £3.74 million, before expenses, by way of a Placing of 3,194,445 new Ordinary Shares at 117 pence per Placing Share. The net proceeds of the Placing, which are expected to amount to approximately £3.54 million, are to be applied, in part, towards the proposed increase of the Company's stake in the CCM Group, its US based minority investment focused on the production of creasing matrix. In addition, part of the net Placing proceeds will be invested in other parts of the Group in order to increase capacity to satisfy increasing demand for the Group's products and thereby accelerate organic growth. FYMar18E rev £62.7m and 35.1m PBT, Div 13p.

 

Scientific Digital Imaging (LON:SDI) 28.5p £25.32m

FY Apr 17 trading update from  group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets. Reported profits before tax are expected to be in line with management's expectations, with the latest acquisition, Astles Control Systems, as expected making a contribution to the profits of the Group. "We have once again strengthened the Group with the recent acquisition and are pleased with the positive contribution from Astles Control Systems. This is a business model we plan to continue to replicate in order to grow a diversified company with increasing revenue streams." FYApr17E £10.7m rev and £1.9m PBT.

Strategic Minerals (LON:SML) 3.1p £38.3m

FY Dec 16 results from  the diversified mineral production and development Company. Maiden profit from operations of $0.351m (loss of $0.880m). Unrestricted cash position $1.105m (2015: $0.946m). Marketing strategies at Cobre resulted in record domestic sales of $1.55m (2015: $1.25m). The Company continues to maintain controls on its overheads, is focused on expanding Cobre's profitable domestic sales, is undertaking further drilling of the CARE tenements, has commenced the Redmoor drilling programme and is examining potential expansionary projects. Now has lower overheads, a strong cash flow stream from Cobre and the potential upside from drilling programmes in Western Australia and in Cornwall.

Powerhouse Energy (LON:PHE) 0.8p £7.65m

The company focused on ultra high temperature gasification waste to energy systems, and the creation of Distributed Modular Gasification© (“DMG”), has appointed  Roudi Baroudi to its recently established Advisory Panel.  Roudi is a global energy expert with over 37 years experience of international public and private companies across oil & gas, petrochemicals, power, energy-sector reform, energy security, carbon trading mechanisms and infrastructure. In addition, he is currently a member of the United Nations Economic Commission for Europe’s Group of Experts of Gas – this is a body established to facilitate dialogue on promoting safe, clean and sustainable solutions for natural gas production.

 

Premaitha Health (LON:NIPT) 13.63p £34.13m

The leading international molecular diagnostics group focused on prenatal testing, announces that the IONA® test, the Company's CE-IVD non-invasive prenatal test ("NIPT"), has been validated for use on Thermo Fisher Scientific's Ion S5 range of instruments. The validation of the IONA® test on the Ion S5 platform, performed in partnership with Thermo Fisher Scientific, will broaden Premaitha's potential laboratory customer base.  The Ion S5 instrument being widely adopted by laboratories carrying out next generation DNA sequencing globally.  The IONA® test is therefore now a possible NIPT solution for this growing network of laboratories. Allows Premaitha to work with laboratories keen to offer NIPT as part of a wider choice of genetic tests.  FYMar17E  rev £4.1m,  £5.9m loss. 

21st Century Technology (LON:C21) 3.25p £3.03m

FYDec16 results from specialist provider of tailored solutions to the transport community. Revenue £11.6m (2015: £12.2m).  Underlying loss £1.4m before tax (2015: underlying profit £0.05m). Cash £0.5m (2015: £1.0m). £0.3m debt raised. £0.4m invoice discounting facility opened. Cost base restructured to generate £1.4m annualised savings Major framework renewals, and innovative new sales. However financial performance in H2 was poor as orders anticipated earlier in the year did not materialise. “We have created a strong platform for growth and are pleased to be looking to the future with confidence."  Moving from standalone CCTV to fully connected systems.  We could see no forecasts.

Caspian Sunrise (LON:CASP) 9.75p £91.4m

The Central Asian oil and gas company, with a focus on Kazakhstan (Formerly Roxi Petroleum), confirms that the Company expects that all conditions for the Baverstock merger and the associated capitalisation of the $10.1 million Vertom loan, will be concluded by 1 June 2017. The proposed merger has been longed planned and once completed will bring 99% of thr principal asset BNG under direct control removing any funding constraints associated with maintaining the current structure. 

Deltex Medical Group (LON:DEMG) 3.62p £10.76m

The company specialising in Oesophageal Doppler Monitoring ("ODM"), has launched its first ODM system designed specifically for veterinary use which has generated £15,000 on release from the first sale of a system to a leading continental Europe Veterinary University. Deltex is planning the marketing launch of the new system for the annual meeting of the International Veterinary Emergency and Critical Care Symposium ('IVECCS') in Nashville, Tennessee in September 2017. In the meantime it is promoting the system to existing contacts. FYDec17E rev £6.8m and £2m loss

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use